Press Releases
Feb. 17, 2026
Genmab Publishes 2025 Annual Report
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
Liva Healthcare and NUPO Announces Partnership with ON LiMiT Research Project
Neutral
EIN Presswire
Jan. 28, 2026
Nordic healthcare gets a voice: Speechmatics cuts medical transcription errors by 40% with new Swedish model
Indeterminate
GlobeNewswire, Inc.
Jan. 27, 2026
Natural Carotenoids Market Expected to Reach USD 708.03 Million by 2035 Amid Rising Functional Nutrition Trends
Indeterminate
GlobeNewswire, Inc.
Jan. 26, 2026
ISS wins full IFS contract for major life sciences and pharmaceutical company in Switzerland
Indeterminate
GlobeNewswire, Inc.
Jan. 21, 2026
AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
Indeterminate
GlobeNewswire, Inc.
Jan. 21, 2026
Cognitive Assessment & Training in Healthcare Market to Surge at 27.06% CAGR, Reaching USD 73.08 Billion by 2034
Indeterminate
GlobeNewswire, Inc.
Jan. 20, 2026
Biologics and Cross-Border Trade Drive the Next Phase of Growth in Cold Chain Pharmaceuticals Market
Indeterminate
GlobeNewswire, Inc.
Feb. 17, 2026
Inside the USD 52.23B Transformation of Biosimilar Contract Manufacturing by 2035
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
Indeterminate
GlobeNewswire, Inc.